NO933140L - Legemiddel for lokal anvendelse på öyet for behandling av forhöyet intraokulart trykk - Google Patents

Legemiddel for lokal anvendelse på öyet for behandling av forhöyet intraokulart trykk

Info

Publication number
NO933140L
NO933140L NO933140A NO933140A NO933140L NO 933140 L NO933140 L NO 933140L NO 933140 A NO933140 A NO 933140A NO 933140 A NO933140 A NO 933140A NO 933140 L NO933140 L NO 933140L
Authority
NO
Norway
Prior art keywords
eye
intraocular pressure
topical application
medication
treatment
Prior art date
Application number
NO933140A
Other languages
English (en)
Other versions
NO933140D0 (no
Inventor
Helmut Franz
Hannes Edgar Kompa
Tibor Rozman
Original Assignee
Basotherm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basotherm Gmbh filed Critical Basotherm Gmbh
Publication of NO933140D0 publication Critical patent/NO933140D0/no
Publication of NO933140L publication Critical patent/NO933140L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

Oppfinnelsen angår en oftalmisk oppløsning for lokal anvendelse på øyet for senkning av et forhøyet intraokulært kammervannstrykk, som inneholder en til senkning av det intraokulære kammervannstrykk virksom mengde av en poly- hydroksyalkohol som sorbitol, mannitol, inositol eller xylitol, eller blandinger av disse, i et for øyet akseptabelt bærermiddel, anvendelsen av denne og dens fremstilling.
NO933140A 1992-09-04 1993-09-03 Legemiddel for lokal anvendelse på öyet for behandling av forhöyet intraokulart trykk NO933140L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4229494A DE4229494A1 (de) 1992-09-04 1992-09-04 Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks

Publications (2)

Publication Number Publication Date
NO933140D0 NO933140D0 (no) 1993-09-03
NO933140L true NO933140L (no) 1994-03-07

Family

ID=6467184

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933140A NO933140L (no) 1992-09-04 1993-09-03 Legemiddel for lokal anvendelse på öyet for behandling av forhöyet intraokulart trykk

Country Status (19)

Country Link
US (1) US5527831A (no)
EP (1) EP0585896B1 (no)
JP (1) JPH06172158A (no)
KR (1) KR940006575A (no)
CN (1) CN1086132A (no)
AT (1) ATE145823T1 (no)
AU (1) AU673533B2 (no)
CA (1) CA2105530A1 (no)
CZ (1) CZ284095B6 (no)
DE (2) DE4229494A1 (no)
DK (1) DK0585896T3 (no)
ES (1) ES2096161T3 (no)
GR (1) GR3022225T3 (no)
HU (1) HU213272B (no)
NO (1) NO933140L (no)
NZ (1) NZ248567A (no)
PL (1) PL300286A1 (no)
SK (1) SK79893A3 (no)
ZA (1) ZA936504B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716819B2 (en) * 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
TW586945B (en) 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
JP2005035969A (ja) * 2003-06-25 2005-02-10 Lion Corp 眼科用組成物及び該組成物の安定化方法
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
WO2007014127A2 (en) * 2005-07-25 2007-02-01 Ion America Corporation Fuel cell system with partial recycling of anode exhaust
HRP20130768T1 (en) * 2007-04-12 2013-10-25 Waratah Pharmaceuticals, Inc. Use of cyclohexanehexol derivatives in the treatment of ocular diseases
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
CA2858574C (en) 2011-12-07 2017-05-30 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
NZ732058A (en) 2014-11-25 2023-06-30 Allergan Inc Stabilized omega-3 ophthalmic compositions
ITUB20153104A1 (it) * 2015-08-13 2017-02-13 Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201706A (en) * 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
DE3167270D1 (en) * 1980-03-21 1985-01-03 Wellcome Found Stabilised ophthalmic formulation
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
DE3700379A1 (de) * 1987-01-08 1988-07-21 Mann Gerhard Chem Pharm Fab Konservierte augentropfen mit einem gehalt an cromoglicinsaeure
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.

Also Published As

Publication number Publication date
GR3022225T3 (en) 1997-04-30
DE4229494A1 (de) 1994-03-10
CA2105530A1 (en) 1994-03-05
PL300286A1 (en) 1994-03-07
SK79893A3 (en) 1994-08-10
US5527831A (en) 1996-06-18
HU213272B (en) 1997-04-28
ZA936504B (en) 1995-03-03
EP0585896A1 (de) 1994-03-09
KR940006575A (ko) 1994-04-25
ES2096161T3 (es) 1997-03-01
ATE145823T1 (de) 1996-12-15
NZ248567A (en) 1995-11-27
HUT64836A (en) 1994-03-28
CZ284095B6 (cs) 1998-08-12
JPH06172158A (ja) 1994-06-21
CN1086132A (zh) 1994-05-04
CZ181193A3 (en) 1994-07-13
EP0585896B1 (de) 1996-12-04
HU9302502D0 (en) 1993-11-29
NO933140D0 (no) 1993-09-03
DE59304658D1 (de) 1997-01-16
DK0585896T3 (da) 1997-04-14
AU673533B2 (en) 1996-11-14
AU4610593A (en) 1994-03-10

Similar Documents

Publication Publication Date Title
NO933140L (no) Legemiddel for lokal anvendelse på öyet for behandling av forhöyet intraokulart trykk
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
ES2042625T5 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
NO975962L (no) Legemiddelpreparat som omfatter albumin som aktiv bestanddel
ES2127375T3 (es) Procedimiento de administracion de un farmaco oftalmico.
AR011192A1 (es) Composiciones oftalmicas que comprenden una prostaglandina y el uso de los mismos en la preparacion de un medicamento para tratar glaucoma
EP0045617A3 (en) Pharmaceutical composition
DK54390D0 (da) Okularcyklosporinpraeparat
CA2059403A1 (en) Use of Carrageenans in Topical Ophthalmic Compositions
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
TW266154B (no)
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
EP0363469A4 (en) Lacrimal secretion stimulant (lss)
ES2141736T3 (es) Gel, especialmente para uso terapeutico ocular.
DE69829062D1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
KR960700711A (ko) 뇌혈관성 질환의 치료 또는 예방용 약제(Medicament for treating or preventing cerebrovascular diseases)
ES2085665T3 (es) Agente neuroprotector.
RISER Modern trends in ocular therapeutics
KOOK et al. Efficacy and Safety of Subconjunctivally Injected 5-fluorouracil after Mitomycin C Trabeculectomy in High Risk Patients
LEE et al. A Case of Endophthalmitis after Laser in situ Keratomi leusisLASIK
EP0826371A4 (en) PREPARATION OF EMEDASTIN FOR EXTERNAL USE
IT1241928B (it) Composizione oftalmica per l'uso nel mantenimento della midriasi oculare
CO4340602A1 (es) Estructura perfeccionada para gafas protectoras
ES2094799T3 (es) Miosis rapida con control de la presion intraocular.